We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Pfizer To Appeal Lipitor Patents In Norway

Law360 (May 29, 2007, 12:00 AM EDT) -- Pfizer Inc. plans to appeal a Norwegian appeals court decision that deemed its Lipitor patents invalid or uninfringed by Ranbaxy's generic version, the company said.

The Norwegian Supreme Court has yet...
To view the full article, register now.